Satellos Bioscience Statistics
Total Valuation
MSLE has a market cap or net worth of $141.43 million. The enterprise value is $88.62 million.
| Market Cap | 141.43M |
| Enterprise Value | 88.62M |
Important Dates
The last earnings date was Thursday, November 12, 2026, before market open.
| Earnings Date | Nov 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MSLE has 21.18 million shares outstanding. The number of shares has increased by 43.41% in one year.
| Current Share Class | 21.22M |
| Shares Outstanding | 21.18M |
| Shares Change (YoY) | +43.41% |
| Shares Change (QoQ) | +1.69% |
| Owned by Insiders (%) | 6.94% |
| Owned by Institutions (%) | 41.92% |
| Float | 18.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.85 |
| P/TBV Ratio | 2.85 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.93, with zero debt.
| Current Ratio | 6.93 |
| Quick Ratio | 6.45 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -95.56% and return on invested capital (ROIC) is -62.08%.
| Return on Equity (ROE) | -95.56% |
| Return on Assets (ROA) | -54.37% |
| Return on Invested Capital (ROIC) | -62.08% |
| Return on Capital Employed (ROCE) | -83.70% |
| Weighted Average Cost of Capital (WACC) | 10.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.90M |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MSLE has paid $173,000 in taxes.
| Income Tax | 173,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.42% in the last 52 weeks. The beta is 1.19, so MSLE's price volatility has been higher than the market average.
| Beta (5Y) | 1.19 |
| 52-Week Price Change | +10.42% |
| 50-Day Moving Average | 7.77 |
| 200-Day Moving Average | 8.34 |
| Relative Strength Index (RSI) | 43.96 |
| Average Volume (20 Days) | 48,175 |
Short Selling Information
The latest short interest is 127,108, so 0.60% of the outstanding shares have been sold short.
| Short Interest | 127,108 |
| Short Previous Month | 97,288 |
| Short % of Shares Out | 0.60% |
| Short % of Float | 0.71% |
| Short Ratio (days to cover) | 1.48 |
Income Statement
| Revenue | n/a |
| Gross Profit | -1.51M |
| Operating Income | -41.53M |
| Pretax Income | -39.78M |
| Net Income | -39.96M |
| EBITDA | -41.53M |
| EBIT | -41.53M |
| Earnings Per Share (EPS) | -$2.09 |
Balance Sheet
The company has $53.01 million in cash and no debt, with a net cash position of $53.01 million or $2.50 per share.
| Cash & Cash Equivalents | 53.01M |
| Total Debt | n/a |
| Net Cash | 53.01M |
| Net Cash Per Share | $2.50 |
| Equity (Book Value) | 49.62M |
| Book Value Per Share | 2.34 |
| Working Capital | 49.62M |
Cash Flow
In the last 12 months, operating cash flow was -$33.11 million and capital expenditures -$4,000, giving a free cash flow of -$33.11 million.
| Operating Cash Flow | -33.11M |
| Capital Expenditures | -4,000 |
| Depreciation & Amortization | 3,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -33.11M |
| FCF Per Share | -$1.56 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MSLE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -43.41% |
| Shareholder Yield | -43.41% |
| Earnings Yield | -31.59% |
| FCF Yield | -23.41% |
Analyst Forecast
The average price target for MSLE is $24.17, which is 264.83% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.17 |
| Price Target Difference | 264.83% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on January 30, 2026. It was a reverse split with a ratio of 1:12.
| Last Split Date | Jan 30, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |